{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:07:22Z","timestamp":1793606842632,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bone.2024.117049","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T08:13:03Z","timestamp":1707984783000},"page":"117049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Successful treatment approaches for tumoral calcinosis in children and young people: A condition of diverse pathogenesis"],"prefix":"10.1016","volume":"182","author":[{"given":"A.","family":"Anilkumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"H\u00f6gler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bursell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nadar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Randell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.J.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Uday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.bone.2024.117049_bb0005","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41574-022-00682-7","article-title":"Skeletal and extraskeletal disorders of biomineralization","volume":"18","author":"Collins","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2024.117049_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-2559.1997.6050831.x","article-title":"Tumoral calcinosis: a clinicopathological study of 111 cases with emphasis on the earliest changes","volume":"31","author":"Pakasa","year":"1997","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.bone.2024.117049_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-4362.1996.tb02999.x","article-title":"Proposal for a pathogenesis-based classification of tumoral calcinosis","volume":"35","author":"Smack","year":"1996","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.bone.2024.117049_bb0020","series-title":"Hyperphosphatemic Familial Tumoral Calcinosis","author":"Ramnitz","year":"1993"},{"issue":"1","key":"10.1016\/j.bone.2024.117049_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00109-004-0610-8","article-title":"Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders","volume":"83","author":"Frishberg","year":"2005","journal-title":"J. Mol. Med."},{"issue":"4","key":"10.1016\/j.bone.2024.117049_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0151-9638(06)70928-0","article-title":"Familial tumoral calcinosis with hyperphosphatemia is heterogeneous and associated with mutations in GALNT3 or FGF-23","volume":"133","author":"Dereure","year":"2006","journal-title":"Ann. Dermatol. Venereol."},{"issue":"1","key":"10.1016\/j.bone.2024.117049_bb0035","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11282-016-0237-9","article-title":"Dental findings of hyperphosphatemic familial tumoral calcinosis","volume":"33","author":"Y\u0131lanc\u0131","year":"2017","journal-title":"Oral Radiol."},{"issue":"6","key":"10.1016\/j.bone.2024.117049_bb0040","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/sj.jid.5701203","article-title":"Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-\u03b1 responsive protein","volume":"128","author":"Chefetz","year":"2008","journal-title":"J. Invest. Dermatol."},{"issue":"4","key":"10.1016\/j.bone.2024.117049_bb0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1086\/508069","article-title":"A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis","volume":"79","author":"Topaz","year":"2006","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.bone.2024.117049_bb0050","first-page":"E170","article-title":"Tumoral calcinosis: what is the treatment? Report of two cases of different types and review of the literature","volume":"40","author":"Farzan","year":"2011","journal-title":"Am. J. Orthop. (Belle Mead N.J.)"},{"issue":"9","key":"10.1016\/j.bone.2024.117049_bb0055","doi-asserted-by":"crossref","first-page":"409","DOI":"10.12998\/wjcc.v2.i9.409","article-title":"Review of tumoral calcinosis: a rare clinico-pathological entity","volume":"2","author":"Fathi","year":"2014","journal-title":"World J. Clin. Cases"},{"issue":"1","key":"10.1016\/j.bone.2024.117049_bb0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1346-8138.1989.tb01226.x","article-title":"Tumoral calcinosis in scleroderma","volume":"16","author":"Katayama","year":"1989","journal-title":"J. Dermatol."},{"issue":"6","key":"10.1016\/j.bone.2024.117049_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0046-8177(95)90164-7","article-title":"Nonfamilial tumoral calcinosis associated with chronic renal failure and secondary hyperparathyroidism: report of two cases with clinicopathological, immunohistochemical, and electron microscopic findings","volume":"26","author":"McGregor","year":"1995","journal-title":"Hum. Pathol."},{"issue":"2","key":"10.1016\/j.bone.2024.117049_bb0070","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4158\/EP.13.2.182","article-title":"Idiopathic sporadic tumoral calcinosis of the hip: successful oral bisphosphonate therapy","volume":"13","author":"Jacob","year":"2007","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.bone.2024.117049_bb0075","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/01.blo.0000157040.96980.bd","article-title":"Tumoral calcinosis in infants: a report of three cases and review of the literature","volume":"436","author":"Hammoud","year":"2005","journal-title":"Clin. Orthop. Relat. Res."},{"issue":"6","key":"10.1016\/j.bone.2024.117049_bb0080","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/ajmg.a.36476","article-title":"Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms","volume":"164","author":"Finer","year":"2014","journal-title":"Am. J. Med. Genet. A"},{"key":"10.1016\/j.bone.2024.117049_bb0085","first-page":"11","article-title":"Hyperphosphatemic tumoral calcinosis: pathogenesis, clinical presentation, and challenges in management","author":"Boyce","year":"2020","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"10","key":"10.1016\/j.bone.2024.117049_bb0090","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.3928\/0147-7447-20041001-23","article-title":"Tumoral calcinosis of the popliteal space","volume":"27","author":"Giardina","year":"2004","journal-title":"Orthopedics"},{"issue":"5","key":"10.1016\/j.bone.2024.117049_bb0095","first-page":"247","article-title":"Surgical complications associated with extensive tumoral calcinosis","volume":"40","author":"King","year":"2011","journal-title":"Am. J. Orthop. (Belle Mead N.J.)"},{"issue":"10","key":"10.1016\/j.bone.2024.117049_bb0100","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/jbmr.2870","article-title":"Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome","volume":"31","author":"Ramnitz","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"10","key":"10.1016\/j.bone.2024.117049_bb0105","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2006-0305","article-title":"The role of mutant UDP-N-acetyl-\u03b1-d-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis","volume":"91","author":"Garringer","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2024.117049_bb0110","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00198-008-0775-z","article-title":"A case of familial tumoral calcinosis\/hyperostosis\u2013hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features","volume":"20","author":"Dumitrescu","year":"2009","journal-title":"Osteoporos. Int."},{"issue":"4","key":"10.1016\/j.bone.2024.117049_bb0115","doi-asserted-by":"crossref","first-page":"247S","DOI":"10.1016\/8756-3282(95)00019-A","article-title":"Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide","volume":"16","author":"Yamaguchi","year":"1995","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2024.117049_bb0120","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000197876","article-title":"Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer","volume":"71","author":"Lammoglia","year":"2009","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/j.bone.2024.117049_bb0125","series-title":"Advances in Experimental Medicine and Biology","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-030-91623-7_10","article-title":"Common dietary sources of natural and artificial phosphate in food","author":"Miyamoto","year":"2022"},{"issue":"1","key":"10.1016\/j.bone.2024.117049_bb0130","first-page":"10","article-title":"Phosphate binders in patients with chronic kidney disease","volume":"40","author":"Chan","year":"2017","journal-title":"Aust. Prescr."},{"issue":"4","key":"10.1016\/j.bone.2024.117049_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/08860229009060727","article-title":"Sodium thiosulfate treatment of tumoral calcinosis in patients with end-stage renal disease","volume":"12","author":"Kyriakopoulos","year":"1990","journal-title":"Ren. Fail."},{"issue":"6","key":"10.1016\/j.bone.2024.117049_bb0140","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1053\/j.ajkd.2004.03.018","article-title":"Successful treatment of calciphylaxis with intravenous sodium thiosulfate","volume":"43","author":"Cicone","year":"2004","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.bone.2024.117049_bb0145","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/ndt\/gfp755","article-title":"Sodium thiosulfate delays the progression of coronary artery calcification in haemodialysis patients","volume":"25","author":"Adirekkiat","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"issue":"7","key":"10.1016\/j.bone.2024.117049_bb0150","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1210\/jc.2016-1087","article-title":"Topical sodium thiosulfate: a treatment for calcifications in hyperphosphatemic familial tumoral calcinosis?","volume":"101","author":"Jost","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bone.2024.117049_bb0155","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1515\/jpem-2020-0359","article-title":"Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate","volume":"34","author":"Emecen Sanli","year":"2021","journal-title":"J. Pediatr. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2024.117049_bb0160","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4274\/jcrpe.galenos.2021.2020.0269","article-title":"The successful treatment of deep soft-tissue calcifications with topical sodium thiosulphate and acetazolamide in a boy with hyperphosphatemic familial tumoral calcinosis due to a novel mutation in FGF23","volume":"14","author":"D\u00f6neray","year":"2022","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"issue":"8","key":"10.1016\/j.bone.2024.117049_bb0165","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1001\/jamadermatol.2013.4565","article-title":"Intralesional sodium thiosulfate for the treatment of calciphylaxis","volume":"149","author":"Strazzula","year":"2013","journal-title":"JAMA Dermatol."},{"issue":"9","key":"10.1016\/j.bone.2024.117049_bb0170","first-page":"1042","article-title":"A novel treatment for ulcerative calcinosis cutis","volume":"10","author":"Bair","year":"2011","journal-title":"J. Drugs Dermatol."},{"issue":"3","key":"10.1016\/j.bone.2024.117049_bb0175","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/bjd.14412","article-title":"Topical sodium metabisulfite for the treatment of calcinosis cutis: a promising new therapy","volume":"175","author":"del Barrio-D\u00edaz","year":"2016","journal-title":"Br. J. Dermatol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224000383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328224000383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T18:07:35Z","timestamp":1757614055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328224000383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":35,"alternative-id":["S8756328224000383"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2024.117049","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment approaches for tumoral calcinosis in children and young people: A condition of diverse pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2024.117049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117049"}}